发明申请
US20100028947A1 USE OF HUMAN CELLS OF MYELOID LEUKAEMIA ORIGIN FOR EXPRESSION OF ANTIBODIES
有权
用于表达抗体的MYELOID LEUKEMIA原始人类细胞的使用
- 专利标题： USE OF HUMAN CELLS OF MYELOID LEUKAEMIA ORIGIN FOR EXPRESSION OF ANTIBODIES
- 专利标题（中）： 用于表达抗体的MYELOID LEUKEMIA原始人类细胞的使用
-
申请号： US12440562申请日： 2007-09-10
-
公开(公告)号： US20100028947A1公开(公告)日： 2010-02-04
- 发明人: Steffen Goletz , Antje Danielczyk , Hans Baumeister , Renate Stahn , Anja Löffler , Lars Stöckl
- 申请人： Steffen Goletz , Antje Danielczyk , Hans Baumeister , Renate Stahn , Anja Löffler , Lars Stöckl
- 优先权： EP06090162.6 20060910; EP06090171.7 20060918; EP06090190.7 20061013; EP07090094.9 20070504
- 国际申请： PCT/EP07/07877 WO 20070910
- 主分类号： C07K14/00
- IPC分类号： C07K14/00 ; C12P21/00 ; C07K16/00 ; C07K14/59 ; C12N5/078 ; C07H21/00
摘要：
The invention relates to a method for producing a protein molecule composition having a defined glycosylation pattern, comprising (a) introducing in a host cell which is an immortalized human blood cell at least one nucleic acid encoding at least a part of said protein; and (b) culturing said host cell under conditions which permit the production of said protein molecule composition; and (c) isolating said protein molecule composition.
公开/授权文献
信息查询
